Zusammenfassung
Die Erforschung der biochemischen, zellulären und subzellulären Mechanismen in der Pathophysiologie des Asthmas hat in den letzten Jahren gezeigt, wie wichtig sterile Entzündungsvorgänge in der Bronchial- schleimhaut zu bewerten sind.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
. Konno S, Asano K, Okamoto K, Adactin M (1994) Inhibition of cytokine production from human perpheral blood leukocytes by anti-allergic agents. Eur J Pharmacol 264: 265 – 268
. Adamus WA, Heur H, Meade CJ, Schilling JC (1990) Inhibitory effects of the new PAF acether
antagonist WEB 2086 on pharmacological changes induced by PAF inhalation in human beings. Clin Pharmacol Ther 47: 456–462
. Robaut C, Mundot S, Florh A, Tahroui L (1988) Pharmacological profile of novel potent and specific PAF rezeptor antagonists. Prostaglandins 35: 838 – 844
. Chung F (1988) New approaches to asthma: antagonists of PAF. New drugs for asthma. IBC, London
. Chung FK (1995) Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. Eur Respir J 8: 1203 – 1213
. von Sprecher A, Beck A, Gerspacher M, Bray MA (1992) Peptidoleukotriene Antagonists, state of the art. Chimia 46: 304 – 331
. Lipworth BJ (1999) Leukotrien-receptor antagonists. Lancet 353: 57 – 62
. Papi A, Caramori G, Fabbri LM (1998) Current asthma therapies and issues in asthma management. Eur Respir Rev 8: 341 – 347
. Lu S, Reiss TF (1998) The dose selection of montelukast sodium (MK-0476). Eur Respir Rev 8: 361 – 365
. Barnes NC (1998) The role of leukotriene receptor antagonists in the management oft asthma. Eur Respir Rev 8: 356 – 357
. Drazen JM, Israel E, Wenzel SE (1998) Should antileukotriene therapie be used instead of inhaled corticosteroids in asthma? Yes or no. Editorial Am J Respir Crit Care Med 158: 1697 – 1701
Tallard RE, Gearing AJH (1994) The cytokine facts book (Acad Press)
. Aggarwal BB, Guttermann JU (1992) Human cytokines: handbook for basic and clinical research. Blackwell Scientific, Oxford
. Rao A (1994) NF-ATp: A transcriptional factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15: 274 – 281
. Akdis CA, Blesken T, Akdis M, Alkan SS, Heusser CH, Blaser K (1997) Glucocorticoids inhibit antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur J Immunol 2351 – 2357
. Wong, RL, Winslaw CM, Cooper KD (1993) The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today 14: 69 – 74
. Erlanger B (1992) Do we know the site of action of cyclosporin? Immunol Today 13: 487 – 489
. Schreiber SC, Cabtree GR (1992) The mecha-nism of action of cyclosporin and FK506. Immunol Today 13: 136 – 142
. Tokuyama H, Tokuyama Y, Nkanishi K (1995) Retinoids inhibit IL-4 dependent IgE and IgG production by LPS-stimulation murine splenic B cells. Cell Immunol 162: 153 – 158
. Redlich CA, Delisser HM, Elias JA (1995) Retinoic acid inhibition of transforming growth factor bbb-induced collagen production by human lung fibroblasts. Am J Resp Cell Mol Biol 12: 287 – 295
. Fegan C, Bailgy-Wood R, Coleman S, Philipps SA, Neale L, Hoy T, Whittaker JA (1995) All-trans retonoic acid enhances human LAK activity. Eur J Haematol 54: 95 – 100
. Chanarin N, Johnston SL (1994) Leukotrienes as a target in asthma therapy. Drugs 47 (1): 12 – 24
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag/Wien
About this chapter
Cite this chapter
Schöni, M.H., Blaser, K. (2000). Hemmer von Mediatoren und Zytokinen. In: Kummer, F., Konietzko, N., Medici, T.C. (eds) Pharmakotherapie bronchopulmonaler Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6761-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6761-8_9
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7404-3
Online ISBN: 978-3-7091-6761-8
eBook Packages: Springer Book Archive